MPRS

MediPress Health-Limited Partnership Stock Price

TASE:MPRS Community·₪7.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

MPRS Share Price Performance

₪0.51
-0.20 (-28.23%)
₪0.51
-0.20 (-28.23%)
Price ₪0.51

MPRS Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

MediPress Health-Limited Partnership Key Details

₪0

Revenue

₪0

Cost of Revenue

₪0

Gross Profit

₪0

Other Expenses

₪0

Earnings

Last Reported Earnings
n/a
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About MPRS

Founded
2021
Employees
n/a
CEO
Joseph Press
Website
n/a

MediPress Health-Limited Partnership, is a research and development life science partnership and venture capital firm specializing in seed/startups investments. The firm seeks to invest in medical research and development companies. Its portfolio companies engage in the treatment of cancer with proton radiation therapy; and the development of non-surgical vaginal solutions for women with various pelvic floor disorders. The firm seeks to take board positions in its portfolio companies. MediPress Health-Limited Partnership was incorporated in 2021 and is based in Ramat Gan, Israel.

Recent MPRS News & Updates

Recent updates

No updates